SIGA Technologies Inc. | Mutual Funds
Mutual Funds that own SIGA Technologies Inc.
iShares Russell 2000 ETF
1,086,641
1.37%
-579
0.02%
09/06/2018
Vanguard Total Stock Market Index Fund
1,017,293
1.29%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
630,300
0.8%
0
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
507,224
0.64%
0
0.04%
09/06/2018
Fidelity Spartan Extended Market Index Fund
208,616
0.26%
0
0.01%
07/31/2018
iShares Micro Cap ETF
139,682
0.18%
0
0.1%
09/06/2018
Fidelity Spartan Total Market Index Fund
136,087
0.17%
0
0%
07/31/2018
Schwab US Small Cap ETF
114,750
0.14%
0
0.01%
09/06/2018
Schwab Small Cap Index Fund
96,800
0.12%
96,800
0.02%
06/30/2018
94,592
0.12%
2,744
0.04%
07/31/2018
| Address |
31 East 62nd Street
New York New York 10065
United States
|
|
Employees
|
- |
| Website |
http://www.siga.com |
| Updated |
07/08/2019 |
| SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. |
